Core Viewpoint - The recent board reshuffle at Huatai Medical signifies a new phase in organizational structure, strategic execution, and governance, aiming for innovation and global expansion in the high-end medical equipment sector [2][11]. Group 1: Board Restructuring - Huatai Medical held its third extraordinary shareholders' meeting on November 21, 2025, to elect the third board of directors, including both non-independent and independent directors [2]. - The first meeting of the new board approved several personnel appointments, with Ge Hao elected as chairman and legal representative, and Cheng Zhenghui appointed as vice chairman and general manager [4]. Group 2: Leadership Background - Ge Hao, born in March 1984, has extensive experience in the medical device industry, having worked at Shenzhen Mindray Bio-Medical Electronics Co., Ltd. since 2008 in various strategic roles [9]. - Since April 2024, Ge Hao has been leading Huatai Medical's strategic planning and capital operations, focusing on high-end medical devices and innovative treatment technologies [10]. Group 3: Future Strategy - The completion of the board reshuffle indicates a smooth transition in management and continuity in strategy, maintaining the company's professional foundation while supporting future business innovation and global expansion [11]. - Huatai Medical plans to adhere to its development strategy of "innovation-driven, quality-oriented," leveraging its professional team and governance system to promote core technology commercialization and sustain steady growth in the medical device industry [11].